Form 4: Skye Bioscience Insider Sells Shares
Insider Transaction (Form 4)
5AM Partners VII, LLC and 7 others reported changes in beneficial ownership of Skye Bioscience, Inc. common stock on September 16, 2026.
Summary
- Open-market sale: disposed of 32,607 Common Stock at $1.91 ($62,279) on September 16, 2026; holds 142,463 after (Indirect).
- Open-market sale: disposed of 1,285 Common Stock at $1.91 ($2,454) on September 16, 2026; holds 5,616 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $64,734 of stock on the open market.
Insider Transactions
5AM Partners VII, LLC — 10% owner
5AM Ventures VII, L.P. — 10% owner
5AM Partners II, LLC — 10% owner
5AM Ventures II LP — 10% owner
5Am Co-Investors Ii Lp — 10% owner
John D Diekman — 10% owner
Kush Parmar — 10% owner
Scott M Rocklage — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 32,607 | $2 | $62.3K | 142,463 |
| 2026-09-16 | Open-market sale | Common Stock | 1,285 | $2 | $2.5K | 5,616 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (32,607 shares) |
| 2026-09-16 | Open-market sale (1,285 shares) |
Keywords
insider transaction, Form 4, SKYE, Skye Bioscience, Inc., bearish, 5AM Partners VII, LLC, 5AM Ventures VII, L.P., 5AM Partners II, LLC, 5AM Ventures II LP, 5Am Co-Investors Ii Lp, John D Diekman, Kush Parmar, Scott M Rocklage
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.